Onesource Specialty Pharma Ltd
NSE:ONESOURCE
Income Statement
Earnings Waterfall
Onesource Specialty Pharma Ltd
Income Statement
Onesource Specialty Pharma Ltd
| Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|
| Revenue | |||||
| Interest Expense |
1 527
|
0
|
0
|
0
|
|
| Revenue |
14 449
N/A
|
12 138
-16%
|
15 215
+25%
|
14 193
-7%
|
|
| Gross Profit | |||||
| Cost of Revenue |
(4 712)
|
(3 177)
|
(4 189)
|
(4 117)
|
|
| Gross Profit |
9 737
N/A
|
8 961
-8%
|
11 027
+23%
|
10 076
-9%
|
|
| Operating Income | |||||
| Operating Expenses |
(7 793)
|
(7 067)
|
(8 577)
|
(8 894)
|
|
| Selling, General & Administrative |
(5 027)
|
(1 896)
|
(2 297)
|
(2 365)
|
|
| Research & Development |
(20)
|
0
|
0
|
0
|
|
| Depreciation & Amortization |
(2 739)
|
(2 241)
|
(2 749)
|
(2 758)
|
|
| Other Operating Expenses |
(7)
|
(2 929)
|
(3 531)
|
(3 771)
|
|
| Operating Income |
1 944
N/A
|
1 894
-3%
|
2 450
+29%
|
1 183
-52%
|
|
| Pre-Tax Income | |||||
| Interest Income Expense |
(1 381)
|
(1 274)
|
(1 407)
|
(1 331)
|
|
| Non-Reccuring Items |
(1 107)
|
(1 034)
|
(1 034)
|
(100)
|
|
| Gain/Loss on Disposition of Assets |
(2)
|
0
|
0
|
0
|
|
| Total Other Income |
(124)
|
149
|
174
|
166
|
|
| Pre-Tax Income |
(671)
N/A
|
(265)
+61%
|
183
N/A
|
(82)
N/A
|
|
| Net Income | |||||
| Tax Provision |
498
|
176
|
223
|
290
|
|
| Income from Continuing Operations |
(173)
|
(89)
|
406
|
208
|
|
| Net Income (Common) |
(180)
N/A
|
(96)
+46%
|
400
N/A
|
201
-50%
|
|
| EPS (Diluted) |
-1.62
N/A
|
-1.03
+36%
|
3.46
N/A
|
1.75
-49%
|
|